Though microcaps and nanocaps carry considerably more volatility than their larger brethren, these 10 with quadruple-digit revenue growth are worth a look.

Investors are wary right now. That means there are small companies with tremendous upside and growth potential… trading at huge discounts.

These biotech trailblazers are revolutionizing new treatments or curing diseases… and they’re extremely overvalued.

Finding the “next big thing” is only one piece of the puzzle. The trickiest part is uncovering which companies in those disruptive sectors are going to produce the biggest gains.

This week, we’re looking at the retailers projected to post the largest revenue wins for the holiday shopping season.

Precious metals are enjoying glittering performances in 2019. It’s a good year to be in gold.

Cannabis companies have been on a terrifying decline for the past six months. And we’re about to dive headlong into earnings season once again.

Investors looking for the safest bets need to start focusing on profits and operating income instead of revenue.

With a lot of consumer spending on the horizon, a trend and seasonal trader like me loves this time of year.

This week we’re looking at the companies at the leading edge of 5G development, ranked by the number of patents they hold.